ScienceDirect to Host French-Language Journals from Elsevier Masson
Forty-five prestigious journals to be launched on ScienceDirect in response to customer demand
Amsterdam, December 12, 2007– Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced that 45 French-language medical journals from Elsevier Masson will be available on ScienceDirect beginning January 3, 2008.
The titles, including Feuillets de Radiologie, Journal de Chirurgie and La Press Médicale, represent a wide range of high-quality journals and complement the 27 Éditions Scientifique et Médicales Elsevier (ESME) titles already hosted on the platform. The importance of this content addition is two-fold: it is a response to growing customer demand in French-speaking territories for French-language content, and it furthers Elsevier’s local-language publishing program, which is making a wealth of important content accessible globally.
“We are always striving to respond positively to customer requests and deliver the content that will help them in their research,” said Jay Katzen, Managing Director, Academic & Government Products. “The addition of this world-class local-language content meets both of these objectives and ensures that ScienceDirect continues to remain a comprehensive and complete platform.”
The 45 titles that will be added date from the early 19th and 20th centuries and have strong ties with some of the most revered French Societies including the French Society of Rheumatology, the French Society of Anaesthesiology and the French Society of Pediatrics. The variety of specialist coverage is notable, with journal subjects ranging from anaesthesiology to pharmacology.
All of the journals to be added consist of high-quality articles, reviews and case reports. In addition, a number of the journals include some abstracts and articles in English. Subscribers will benefit from the current (2008) articles as well as four years in backfiles.
The Elsevier Masson collection on ScienceDirect will evolve with new titles added each year through new launches and acquisitions. For more information on ScienceDirect and for a complete list of titles that will be added, please visit www.info.sciencedirect.com.
# # #
Over a quarter of the world's full text scientific, technical and medical (STM) articles - managed by renowned editors, written by respected authors and read by researchers from around the globe - are available in one place: ScienceDirect (http://www.sciencedirect.com).
Elsevier's extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over eight million articles are available online, including Articles in Press which offer rapid access to recently accepted manuscripts. The critical mass of information available on ScienceDirect is unsurpassed. Coverage includes over 2,000 journals published by Elsevier and dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. An expanding program of online major reference works, handbooks, book series and eBooks in all fields of science seamlessly interlinks with primary research referenced in journal articles.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).